MiR-186-3p attenuates tumorigenesis of cervical cancer by targeting IGF1

World J Surg Oncol. 2021 Jul 12;19(1):207. doi: 10.1186/s12957-021-02317-z.

Abstract

Background: Mounting evidence in the cancer literature suggests that microRNAs (miRNAs) influence the progression of human cancer cells by targeting protein-coding genes. How insulin-like growth factor 1(IGF1) and miR-186-3p contribute to the development of cervical cancer (CC) remains unclear. This study examined the regulatory roles of miR-186-3p and IGF1 in CC development.

Methods: Gene expression levels were determined by qRT-PCR. Proliferation, migration, and apoptosis of CC and normal cells were determined by MTT, Transwell, and caspase-3 activity assays, respectively. Dual-luciferase reporter activity and RNA pull-down assays were performed to identify the target gene of miR-186-3p.

Results: IGF1 was the target of miR-186-3p. The expression of miR-186-3p inhibited cell proliferation and migration abilities of CC cell lines, but induced the apoptosis rate of CC cells. IGF1 could restore the inhibitory effects of miR-186-3p on the proliferation, migration, and apoptosis abilities of CC cells. Experimental results revealed that miR-186-3p could inhibit IGF1 expression, thereby reducing the viability of CC cells.

Conclusions: The data suggest that targeting of IGF1 by miR-186-3p could be crucial in regulating the progression of CC.

Keywords: Apoptosis; Cervical cancer; IGF1; Migration; Proliferation; miR-186-3p.

MeSH terms

  • Apoptosis
  • Carcinogenesis / genetics
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Insulin-Like Growth Factor I / genetics
  • MicroRNAs* / genetics
  • Prognosis
  • Uterine Cervical Neoplasms* / genetics

Substances

  • IGF1 protein, human
  • MIRN186 microRNA, human
  • MicroRNAs
  • Insulin-Like Growth Factor I